GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ablynx NV (XBRU:ABLXS) » Definitions » 5-Year Yield-on-Cost %

Ablynx NV (XBRU:ABLXS) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 20, 2024)


View and export this data going back to . Start your Free Trial

What is Ablynx NV 5-Year Yield-on-Cost %?

Ablynx NV's yield on cost for the quarter that ended in Dec. 2017 was 0.00.


The historical rank and industry rank for Ablynx NV's 5-Year Yield-on-Cost % or its related term are showing as below:



XBRU:ABLXS's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.89
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Ablynx NV's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Ablynx NV's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ablynx NV's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ablynx NV's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Ablynx NV's 5-Year Yield-on-Cost % falls into.



Ablynx NV 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Ablynx NV is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Ablynx NV  (XBRU:ABLXS) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Ablynx NV 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Ablynx NV's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ablynx NV (XBRU:ABLXS) Business Description

Traded in Other Exchanges
N/A
Address
Ablynx NV is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. It has 45 proprietary and partnered programs in development in various therapeutic areas including inflammation, hematology, immuno-oncology, oncology and respiratory disease. It has collaborations with multiple pharmaceutical companies including AbbVie; Boehringer Ingelheim; Eddingpharm; Merck & Co., Inc., Kenilworth, New Jersey, USA; Merck KGaA; Novartis; Novo Nordisk; Sanofi and Taisho Pharmaceuticals. The company generates revenue from research collaboration agreements and from government grants.

Ablynx NV (XBRU:ABLXS) Headlines

No Headlines